phototechno/iStock via Getty Images BioRestorative Therapies ( NASDAQ: BRTX ) said on Friday it had received a Nasdaq notice stating that the company was not in compliance with the stock exchange's listing rules. According to the Nasdaq notice, BRTX failed to timely file its Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2024. BRTX has 60 days, or until July 22, 2024, to submit to Nasdaq a plan to regain compliance with the Nasdaq listing rules.
If Nasdaq accepts BRTX's plan, then Nasdaq may grant BRTX an exception of up to 180 calendar days from the filing's due date, or until November 18, 2024, to regain compliance. The company said that the Nasdaq notice has no immediate effect on the listing or trading of its securities. Press Release More on BioRestorative Therapies BioRestorative Therapies, Inc.
(BRTX) Q1 2024 Earnings Call Transcript BioRestorative gains as FDA clears amendment to study on cell therapy candidate Seeking Alpha’s Quant Rating on BioRestorative Therapies Historical earnings data for BioRestorative Therapies Financial information for BioRestorative Therapies.